News
Release time:2024-12-31
As a non-invasive, low-risk and effective treatment, electrical stimulation therapy is showing its great potential in many fields such as neurorehabilitation, pain management, and mental illness treatment. Against this background, Nanochap has revolutionized electrical stimulation devices with its innovative NNC6121 highly integrated programmable stimulation chip.

Traditional electrical stimulation equipment is difficult to meet the modern medical demand for efficient, convenient and personalized treatment due to complex design, large size and high production cost. At the same time, with the increasing requirements for safety and stability in the medical field, the stability and reliability of traditional electrical stimulation devices are facing serious challenges. Therefore, the development of a highly integrated, programmable, stable, reliable and low-cost medical chip has become an important issue in the field of medical electronic devices.
The R&D process of NNC6121 chip is full of challenges. In order to achieve a high degree of integration, the R&D team needs to integrate a variety of functional modules, including ARM microcontroller, configurable boost DC converter, multi-channel high flexibility stimulus driver circuit, etc., within a limited chip area. This requires not only an in-depth understanding of the synergies between the modules, but also a high level of integration skill.
Secondly, programmability is another highlight of the NNC6121 chip, and also a major difficulty in the development process. In order to realize this function, the R&D team needs to design a set of efficient and flexible programming interfaces, so that users can flexibly configure and adjust the chip's operating parameters, such as the stimulus waveform, frequency, pulse width, amplitude, etc., according to specific therapeutic needs. This not only requires deep technical accumulation, but also requires an in-depth understanding of the user's needs and accurate grasp.

With its excellent performance and wide range of applications, the NNC6121 chip has been widely used in medical electronic equipment. Taking neurological rehabilitation equipment as an example, the NNC6121 chip can provide single-channel stimulation current output of up to 67mA and support arbitrary waveforms. Whether it is a continuous wave or pulse wave required by neurological rehabilitation patients, or a modulated wave or complex waveform required by chronic pain patients, the NNC6121 chip is able to provide accurate and stable stimulation output to help patients accelerate the recovery process.
The NNC6121 chip is also widely used in pain management devices. Through appropriate stimulation parameters, the NNC6121 chip can effectively relieve patients' acute and chronic pain and improve their quality of life. In the field of psychological disease treatment, the programmability of the NNC6121 chip also allows the treatment parameters to be adjusted according to the patient's specific situation, so as to better meet the patient's treatment needs.

The core technical advantages of NNC6121 chip are mainly reflected in the following aspects:
1. highly integrated: NNC6121 chip integrated ARM microcontroller, configurable boost DC converter and multi-channel high flexibility stimulation drive circuit and other complex functional modules, to achieve an unprecedented high degree of integration, greatly reducing the size of the device, reducing production costs.
2. Programmability: NNC6121 chip through a dedicated programming interface, so that users can be based on specific therapeutic needs, flexible configuration and adjustment of the chip's operating parameters, such as stimulation waveform, frequency, pulse width, amplitude, etc., so as to achieve a fine regulation of the output of electrical stimulation.
3. High stability and reliability: NNC6121 chip adopts advanced design and manufacturing process, which ensures the stability and reliability of the system, and ensures the precise control and safety in the process of electrical stimulation.
4. Constant current source technology: NNC6121 chip adopts constant current source technology, which can control the stimulation current more stably, and at the same time, the current waveform of the constant current source output can be kept relatively stable after entering the human body, which avoids the damage that may be caused by the traditional constant voltage source technology to the peripheral tissues in the human body.
As an innovative achievement of Nanochap Electronic Technology Co., Ltd, the NNC6121 chip not only overcame many challenges during the research and development process, but also demonstrated excellent performance and a wide range of applications in practical use. Its core technology advantages provide strong support for the intelligence, personalization and efficiency of electrical stimulation devices.
Follow us
Get in touch
Nanochap Electronics Co., Ltd
Melbourne: Suite 3, Level 4, 10 Queens road, Melbourne, VIC 3004, Australia.
Phone: +61432800985
Ho Chi Minh city: Level 19, TTC Building, 253 Hoang Van Thu, Ward 2, Tan Binh District, Ho Chi Minh city, Vietnam.
Phone: +84967096581